Bicycle Therapeutics (BCYC) Non-cash Items (2018 - 2026)
Bicycle Therapeutics posted quarterly Non-cash Items of $7.3 million for Q1 2026, up 20.47% year-on-year from $6.0 million in Q1 2025, and up 170.72% on a QoQ basis from $2.7 million in Q4 2025.
Bicycle Therapeutics (BCYC) has 9 years of Non-cash Items data on file, last reported at $7.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non-cash Items rose 20.47% year-over-year to $7.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (up 20.47% YoY), and the FY2025 full-year result was $2.7 million, down 49.99% from the prior year.
- Non-cash Items for Q1 2026 stood at $7.3 million, up from $2.7 million in the prior quarter.
- Across five years, Non-cash Items topped out at $130.4 million in Q1 2022 and bottomed at $2.7 million in Q2 2025.
- The 5-year median for Non-cash Items is $5.1 million (2024), against an average of $19.4 million.
- Peak annual rise in Non-cash Items reached 6362.45% in 2022, while the deepest fall reached 97.5% in 2022.
- A 5-year view of Non-cash Items shows it stood at $71.0 million in 2022, then sank by 69.13% to $21.9 million in 2023, then tumbled by 56.39% to $9.6 million in 2024, then sank by 71.96% to $2.7 million in 2025, then jumped by 170.72% to $7.3 million in 2026.
- The last three Non-cash Items figures came in at $7.3 million (Q1 2026), $2.7 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.26 Mn |
| Mar 31, 2026 | 7.26 Mn |
| Dec 31, 2025 | 2.68 Mn |
| Dec 31, 2025 | 2.68 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 6.02 Mn |
| Mar 31, 2025 | 6.02 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Sep 30, 2024 | 5.09 Mn |
| Sep 30, 2024 | 5.09 Mn |
| Jun 30, 2024 | 30.75 Mn |
| Jun 30, 2024 | 30.75 Mn |
| Mar 31, 2024 | 4.96 Mn |
| Mar 31, 2024 | 4.96 Mn |
| Dec 31, 2023 | 21.92 Mn |
| Dec 31, 2023 | 21.92 Mn |
| Sep 30, 2023 | 4.33 Mn |
| Sep 30, 2023 | 4.33 Mn |
| Jun 30, 2023 | 4.08 Mn |
| Jun 30, 2023 | 4.08 Mn |
| Mar 31, 2023 | 3.78 Mn |
| Mar 31, 2023 | 3.78 Mn |
| Dec 31, 2022 | 71.00 Mn |
| Dec 31, 2022 | 71.00 Mn |
| Sep 30, 2022 | 3.18 Mn |
| Sep 30, 2022 | 3.18 Mn |
| Jun 30, 2022 | 18.51 Mn |
| Jun 30, 2022 | 18.51 Mn |
| Mar 31, 2022 | 130.44 Mn |
| Mar 31, 2022 | 130.44 Mn |
| Dec 31, 2021 | 207.01 Mn |
| Dec 31, 2021 | 207.01 Mn |
| Sep 30, 2021 | 127.32 Mn |
| Sep 30, 2021 | 127.32 Mn |
| Jun 30, 2021 | 2.17 Mn |
| Jun 30, 2021 | 2.17 Mn |
| Mar 31, 2021 | 2.02 Mn |
| Mar 31, 2021 | 2.02 Mn |
| Dec 31, 2020 | 27.55 Mn |
| Dec 31, 2020 | 27.55 Mn |
| Sep 30, 2020 | 33.34 Mn |
| Sep 30, 2020 | 33.34 Mn |
| Jun 30, 2020 | 21.38 Mn |
| Jun 30, 2020 | 21.38 Mn |
| Mar 31, 2020 | 984,491.00 |
| Mar 31, 2020 | 984,491.00 |
| Dec 31, 2019 | 6.11 Mn |
| Dec 31, 2019 | 6.11 Mn |
| Sep 30, 2019 | 9.09 Mn |
| Sep 30, 2019 | 9.09 Mn |
| Jun 30, 2019 | 8.31 Mn |
| Jun 30, 2019 | 8.31 Mn |
| Dec 31, 2018 | 3.29 Mn |
| Dec 31, 2018 | 3.29 Mn |